How far has the stock of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) come to trade at their current price of $6.73, which gives it a market cap of $579.79M.
To trade now at $6.73, the stock has emerged from a 52-week low of $158.85%. But the current price also compares with the 52-week peak of $-27.24%.
The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Weak.
The stock’s journey to the current price can be understood by looking at its performance from the last week down to the 12 months. The stock’s weekly performance stands at 14.65% and its monthly performance is 6.32%%. For the quarter, the stock has moved 22.59% and for half-year it has shifted 14.07%. So far this year the stock has moved 100.90% and for the last 12 months it has moved 6.32%.
Studying simple moving averages also tell the stock?s journey thus far. The 20-Day Simple Moving Average is $15.47%, the 50-Day Simple Moving Average is $-3.39%, while the 200-Day Simple Moving Average is $15.48%.
In terms of financial performance, BioCryst Pharmaceuticals, Inc. reported gross margin of 92.60% for the trailing 12 months.
BioCryst Pharmaceuticals, Inc.’s P/Cash for the most recent quarter is 5.87, while P/Free Cash Flow for the trailing 12 months is -. Dividend yield and payout ratio calculate to – and -. For perspective, payout ratio provides insight into a company’s ability to sustain dividend distributions. As such, a lower payout ratio is preferred to a higher payout ratio is it implies a company is preserving more cash for investments and other needs that it releases to shareholders.
This report is for information purposes only, and is neither a solicitation or recommendation to buy nor an offer to sell securities. Financials Trend is not-a-registered-investment-advisor. Financials Trend is not a broker-dealer. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. Financials Trend accepts no liability for any losses arising from an investor's reliance on the use of this material. Financials Trend sometimes gets compensated up to one hundred and fifty thousand dollars per month for featuring particular stocks. See site disclaimer for complete compensation. Financials Trend and its affiliates or officers currently hold no shares of these stocks. Financials Trend and its affiliates or officers will purchase and sell shares of common stock of these stocks, in the open market at any time without notice. Financials Trend will not update its purchases and sales of these stocks in any future postings on Financials Trend's websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words "may", "would," "will," "expect," "estimate," "anticipate," "believe," "intend," " project," and similar expressions and variations thereof are intended to identify for ward-looking statements. Such forward- looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *Financials Trend does not set price targets on securities. Never invest into a stock discussed on this web site or in this email alert unless you can afford to lose your entire investment.